Loading clinical trials...
Loading clinical trials...
A Phase III, Open Label, Multicentre Randomised Clinical Study Comparing Acelarin (NUC-1031) With Gemcitabine in Patients With Metastatic Pancreatic Carcinoma
Conditions
Interventions
Acelarin
Gemcitabine
Locations
1
United Kingdom
Cancer Research UK Liverpool Cancer Trials Unit
Liverpool, Merseyside, United Kingdom
Start Date
December 1, 2015
Primary Completion Date
September 1, 2020
Completion Date
December 1, 2022
Last Updated
October 29, 2019
NCT06885697
NCT07139236
NCT07035587
NCT06953193
NCT05218889
NCT06538623
Lead Sponsor
The Clatterbridge Cancer Centre NHS Foundation Trust
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions